Regeneron, Sanofi Didn't Warn About Cancer Risk, Suit Says
By Kelcey Caulder · March 4, 2026, 8:09 PM EST
Regeneron Pharmaceuticals and Sanofi-Aventis were sued Tuesday in Georgia federal court by a woman who said she experienced rapid progression of cutaneous T-cell lymphoma after getting injections of dupilumab, a medication...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login